For citations:
Litvinchuk D.V., Danilau D.E., Paduto V.D., Dyrykau D.V., Suleuski M.I., Kirpichenko A.N., Bas I.S., Kozorez E.I., Anishchanka A.V., Anisko L.A., Karpov I.A. MORTALITY RISK PREDICTION IN PATIENTS TREATED WITH REMDESIVIR FOR SARS-CoV-2 OMICRON INFECTION. Medical Journal. 2026;(3):73-79. (In Russ.) https://doi.org/10.51922/1818-426X.2026.3.73
JATS XML
Email this article 